Menu Search
Equities

Tandem Diabetes Care Inc

TNDM:NMQ

Tandem Diabetes Care Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)30.60
  • Today's Change-2.72 / -8.16%
  • Shares traded3.32m
  • 1 Year change+97.16%
  • Beta1.3350
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Tandem Diabetes Care Inc's revenues fell -6.68% from 801.22m to 747.72m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 94.59m to a larger loss of 222.61m.
Gross margin49.79%
Net profit margin-14.84%
Operating margin-15.79%
Return on assets-13.36%
Return on equity-45.96%
Return on investment-17.47%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Tandem Diabetes Care Inc fell by 113.65m. Cash Flow from Financing totalled 4.11m or 0.55% of revenues. In addition the company used 31.81m for operations while cash used for investing totalled 85.74m.
Cash flow per share-1.69
Price/Cash flow per share--
Book value per share3.62
Tangible book value per share3.62
More ▼

Balance sheet in USDView more

Tandem Diabetes Care Inc has a Debt to Total Capital ratio of 59.45%, a lower figure than the previous year's 90.63%.
Current ratio2.90
Quick ratio2.32
Total debt/total equity1.47
Total debt/total capital0.5945
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.